1 / 6

Global Vaccines Market to witness growth of 9% CAGR from 2017 to 2024

Get more details @ http://bit.ly/2zKasVN <br>Some of the major players in vaccines market are AstraZeneca, Abbott, Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, Sanofi Pasteur, Pfizer, GlaxoSmithKline, Emergent BioSolutions, Novartis, Astellas Pharma, CSL and Novavax.

jueekate
Télécharger la présentation

Global Vaccines Market to witness growth of 9% CAGR from 2017 to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Vaccines Market share to surpass $65 Bn by 2024: Global Market Insights Inc.

  2. Key Insights from VaccinesMarket: • Global Market Insights, Inc. says, Global Vaccines Market size is set to exceed USD 65 billion by 2024. • Introduction of innovative technologies in vaccination, rising government support for product development will stimulate global vaccines market growth over the coming years. • Growing awareness towards preventive vaccination in pediatric and increasing adoption of therapeutic vaccines in cancer treatment will fuel industry growth. • Increasing disease prevalence in underdeveloped countries coupled with growing incidence of cancer & HIV will serve as high impact rendering factor for the business growth. • Pediatric will grow at a significant rate over the forecast period owing to CDC recommendation for immunization schedule to protect children and infants before getting exposed to potentially life-threatening diseases. • Attenuated vaccines will grow at a substantial rate over the forecast period pertaining to factors such as robust antibody and cellular responses, and frequently deliberate lifelong immunity with only one or two doses.

  3. Continued... • Influenza will witness considerable growth due to growing incidence, mounting number of disease-causing microbes (pathogens) and rising awareness in emerging economies towards disease prevention. • U.S. vaccines market will witness significant growth over the forecast period pertaining to enormous impact of immunization on improving health of children and protecting them with vaccines due to epidemics of preventable diseases like mumps, pertussis, and measles. • Some of the companies operating in industry are Abbott, AstraZeneca, Astellas Pharma, Bristol-Myers Squibb, CSL, Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Novavax, Pfizer and Sanofi Pasteur. • New product launches and expansion of existing product portfolio will mainly drive the business growth. Major industry participants will endeavor to fortify their market position by adopting these strategies.

  4. U.S. Vaccines Market, By Age Group, 2013 - 2024 (USD Billion)

  5. Browse Full Market Research Report On Vaccines Market @ http://bit.ly/2A49oxa Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/2186https://www.gminsights.com/request-sample/detail/49

  6. Stay In Touch Website: www.gminsights.com Social Media:

More Related